News – Page 845 – Endpoints News

Joining Novartis in siRNA space, AstraZeneca hands Silence $80M upfront for discovery deal

6 years ago

Turn on, tune in: New York biotech scores $15M+ in chemogenetics bet

6 years ago

FDA opens door to emergency use of convalescent plasma from recovered Covid-19 patients

6 years ago

Novartis announces positive data from halted Zolgensma trial

6 years ago

Covid-19 roundup: Where is Dr. Fauci?; ASCO goes virtual

6 years ago

How to build CAR–M: Carl June protégé and his biotech publish first evidence in Nature Biotechnology

6 years ago

Despite protests, Milestone Pharma gets clobbered by a PhIII crash in the clinic

6 years ago

BPCIA turns 10: Nearly 100 drugs become biologics

6 years ago

Four years after near-death experience, PhIII data bring good news for Novavax

6 years ago

'I have a feeling': Trump-endorsed malaria drug fails to pass muster in small Chinese coronavirus study

6 years ago

Astellas empowers newly energized CytomX with $80M upfront to get preclinical bispecific work going

6 years ago

BELLUS Health buys IP rights, banishes royalties; AbbVie gets confirmatory data on accelerated AML drug

6 years ago

Bayer inks up with “small” Indian biotech for new approach at an old target

6 years ago

Caught in a Covid-19 maelstrom, Eli Lilly locks down clinical trials as multibillion-dollar R&D ops derail

6 years ago

Covid-19 roundup: FDA stamps quick OK on Roche's Actemra PhIII; AlloVir expands Baylor pact

6 years ago

No surprise: After near unanimous adcomm, FDA rejects Eli Lilly bid to bring Jardiance to type 1 patients

6 years ago

Inundated by demand, Gilead halts individual emergency access to experimental Covid-19 drug

6 years ago

Covid-19 roundup: Italy death toll officially tops China; US company plans roll out of at-home specimen collection ...

6 years ago

FDA revamps adverse event reporting guidance for Covid-19

6 years ago

A key player behind 2 multibillion-dollar biotech M&A deals is back in the startup business

6 years ago

Charles Bancroft makes quick leap from Bristol Myers exec team to GSK; Medicxi adds two new partners to its team

6 years ago

J&J pitches its S1P1 MS drug into the regulatory ring as the competition heats up fast

6 years ago

InnoCare IPO oversubscribed 300x as Hong Kong investors turned to biotech amid runoff

6 years ago

No, Mr. President, you can’t just order up outbreak meds with the snap of your fingers

6 years ago

First page Previous page 842 843 844845846 847 848 Next page Last page